These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 36791581

  • 1. Interactions between the regulatory peptide 26RFa (QRFP) and insulin in the regulation of glucose homeostasis in two complementary models: The high fat 26RFa-deficient mice and the streptozotocin insulin-deficient mice.
    Le Solliec MA, Arabo A, Takhlidjt S, Maucotel J, Devère M, Berrahmoune H, Bénani A, Nedelec E, Lefranc B, Leprince J, Picot M, Chartrel N, Prévost G.
    Neuropeptides; 2023 Apr; 98():102326. PubMed ID: 36791581
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptide 26RFa (QRFP) is a key regulator of glucose homeostasis and its activity is markedly altered in obese/hyperglycemic mice.
    Prévost G, Arabo A, Le Solliec MA, Bons J, Picot M, Maucotel J, Berrahmoune H, El Mehdi M, Cherifi S, Benani A, Nédélec E, Coëffier M, Leprince J, Nordqvist A, Brunel V, Déchelotte P, Lefebvre H, Anouar Y, Chartrel N.
    Am J Physiol Endocrinol Metab; 2019 Jul 01; 317(1):E147-E157. PubMed ID: 31084498
    [Abstract] [Full Text] [Related]

  • 3. Acute but Not Chronic Central Administration of the Neuropeptide 26RFa (QRFP) Improves Glucose Homeostasis in Obese/Diabetic Mice.
    Le Solliec MA, Arabo A, Takhlidjt S, Maucotel J, Devère M, Riancho J, Berrahmoune H, do Rego JL, do Rego JC, Bénani A, Nedelec E, Lefranc B, Leprince J, Anouar Y, Picot M, Chartrel N, Prévost G.
    Neuroendocrinology; 2022 Jul 01; 112(11):1104-1115. PubMed ID: 35093951
    [Abstract] [Full Text] [Related]

  • 4. Glucose homeostasis is impaired in mice deficient in the neuropeptide 26RFa (QRFP).
    El-Mehdi M, Takhlidjt S, Khiar F, Prévost G, do Rego JL, do Rego JC, Benani A, Nedelec E, Godefroy D, Arabo A, Lefranc B, Leprince J, Anouar Y, Chartrel N, Picot M.
    BMJ Open Diabetes Res Care; 2020 Feb 01; 8(1):. PubMed ID: 32114486
    [Abstract] [Full Text] [Related]

  • 5. The 26RFa (QRFP)/GPR103 neuropeptidergic system in mice relays insulin signalling into the brain to regulate glucose homeostasis.
    El Mehdi M, Takhlidjt S, Devère M, Arabo A, Le Solliec MA, Maucotel J, Bénani A, Nedelec E, Duparc C, Lefranc B, Leprince J, Anouar Y, Prévost G, Chartrel N, Picot M.
    Diabetologia; 2022 Jul 01; 65(7):1198-1211. PubMed ID: 35476025
    [Abstract] [Full Text] [Related]

  • 6. Hypothalamic Neuropeptide 26RFa Acts as an Incretin to Regulate Glucose Homeostasis.
    Prévost G, Jeandel L, Arabo A, Coëffier M, El Ouahli M, Picot M, Alexandre D, Gobet F, Leprince J, Berrahmoune H, Déchelotte P, Malagon M, Bonner C, Kerr-Conte J, Chigr F, Lefebvre H, Anouar Y, Chartrel N.
    Diabetes; 2015 Aug 01; 64(8):2805-16. PubMed ID: 25858563
    [Abstract] [Full Text] [Related]

  • 7. The Neuropeptide 26RFa (QRFP) and Its Role in the Regulation of Energy Homeostasis: A Mini-Review.
    Chartrel N, Picot M, El Medhi M, Arabo A, Berrahmoune H, Alexandre D, Maucotel J, Anouar Y, Prévost G.
    Front Neurosci; 2016 Aug 01; 10():549. PubMed ID: 27965532
    [Abstract] [Full Text] [Related]

  • 8. Prolonged β2-adrenergic agonist treatment improves glucose homeostasis in diet-induced obese UCP1-/- mice.
    van Beek SMM, Kalinovich A, Schaart G, Bengtsson T, Hoeks J.
    Am J Physiol Endocrinol Metab; 2021 Mar 01; 320(3):E619-E628. PubMed ID: 33522400
    [Abstract] [Full Text] [Related]

  • 9. Gdf11 gene transfer prevents high fat diet-induced obesity and improves metabolic homeostasis in obese and STZ-induced diabetic mice.
    Lu B, Zhong J, Pan J, Yuan X, Ren M, Jiang L, Yang Y, Zhang G, Liu D, Zhang C.
    J Transl Med; 2019 Dec 17; 17(1):422. PubMed ID: 31847906
    [Abstract] [Full Text] [Related]

  • 10. CTRP1 prevents high fat diet-induced obesity and improves glucose homeostasis in obese and STZ-induced diabetic mice.
    Ren M, Pan J, Yu X, Chang K, Yuan X, Zhang C.
    J Transl Med; 2022 Oct 04; 20(1):449. PubMed ID: 36195912
    [Abstract] [Full Text] [Related]

  • 11. The neuropeptide 26RFa in the human gut and pancreas: potential involvement in glucose homeostasis.
    Prévost G, Picot M, Le Solliec MA, Arabo A, Berrahmoune H, El Mehdi M, Cherifi S, Benani A, Nédélec E, Gobet F, Brunel V, Leprince J, Lefebvre H, Anouar Y, Chartrel N.
    Endocr Connect; 2019 Jul 04; 8(7):941-951. PubMed ID: 31234144
    [Abstract] [Full Text] [Related]

  • 12. Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice.
    Gupta AP, Garg R, Singh P, Goand UK, Syed AA, Valicherla GR, Riyazuddin M, Mugale MN, Gayen JR.
    Eur J Pharmacol; 2020 Aug 15; 881():173204. PubMed ID: 32439261
    [Abstract] [Full Text] [Related]

  • 13. [The neuropeptide 26RFa and its role in the regulation of energy metabolism].
    Chartrel N, Prévost G, El Medhi M, Arabo A, Berrahmoune H, Maucotel J, Anouar Y, Picot M.
    Biol Aujourdhui; 2016 Aug 15; 210(4):227-235. PubMed ID: 28327281
    [Abstract] [Full Text] [Related]

  • 14. The 26RFa (QRFP)/GPR103 Neuropeptidergic System: A Key Regulator of Energy and Glucose Metabolism.
    Devère M, Takhlidjt S, Prévost G, Chartrel N, Leprince J, Picot M.
    Neuroendocrinology; 2024 Apr 10; ():1-17. PubMed ID: 38599200
    [Abstract] [Full Text] [Related]

  • 15. Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice.
    Balakumar M, Prabhu D, Sathishkumar C, Prabu P, Rokana N, Kumar R, Raghavan S, Soundarajan A, Grover S, Batish VK, Mohan V, Balasubramanyam M.
    Eur J Nutr; 2018 Feb 10; 57(1):279-295. PubMed ID: 27757592
    [Abstract] [Full Text] [Related]

  • 16. PAQR9 regulates glucose homeostasis in diabetic mice and modulates insulin secretion in β cells in vitro under stress conditions.
    Li Z, Lin Y, Zhuo S, Chen J, Chen L, Wang S, Chen Y.
    Mol Cell Endocrinol; 2023 Sep 15; 575():112032. PubMed ID: 37499998
    [Abstract] [Full Text] [Related]

  • 17. Mice Deficient in Proglucagon-Derived Peptides Exhibit Glucose Intolerance on a High-Fat Diet but Are Resistant to Obesity.
    Takagi Y, Kinoshita K, Ozaki N, Seino Y, Murata Y, Oshida Y, Hayashi Y.
    PLoS One; 2015 Sep 15; 10(9):e0138322. PubMed ID: 26378455
    [Abstract] [Full Text] [Related]

  • 18. Tbc1d1 deletion suppresses obesity in leptin-deficient mice.
    Dokas J, Chadt A, Joost HG, Al-Hasani H.
    Int J Obes (Lond); 2016 Aug 15; 40(8):1242-9. PubMed ID: 27089993
    [Abstract] [Full Text] [Related]

  • 19. Peptide-YY3-36/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic β-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries.
    Boland BB, Laker RC, O'Brien S, Sitaula S, Sermadiras I, Nielsen JC, Barkholt P, Roostalu U, Hecksher-Sørensen J, Sejthen SR, Thorbek DD, Suckow A, Burmeister N, Oldham S, Will S, Howard VG, Gill BM, Newton P, Naylor J, Hornigold DC, Austin J, Lantier L, McGuinness OP, Trevaskis JL, Grimsby JS, Rhodes CJ.
    Mol Metab; 2022 Jan 15; 55():101392. PubMed ID: 34781035
    [Abstract] [Full Text] [Related]

  • 20. Diabetes recurrence after metabolic surgeries correlates with re-impaired insulin sensitivity rather than beta-cell function.
    Liu T, Zhong MW, Liu Y, Sun D, Wei M, Huang X, Cheng YG, Wu QZ, Wu D, Zhang XQ, Wang KX, Hu SY, Liu SZ.
    World J Gastroenterol; 2017 May 21; 23(19):3468-3479. PubMed ID: 28596682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.